To mitigate the human subjectivity and repetitive work inherent in breast cancer screening, Vara has secured $6.0M in Seed funding for its AI-powered software platform. The company, which developed its technology with screening radiologists in Germany, aims to make mammography readings more effective, measurable, and accessible globally.
Investors Merantix and HealthTech Venture Funds backed the round, supporting Vara's mission to democratize early screening and deliver measurable impact backed by clinical evidence where it is needed most.


















